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Abstract A patient with a female phenotype, 46,XY karyo-
type, and a diagnosis of complete androgen insensitivity syn-
drome (CAIS) was examined. Her mother and three 46,XX
sisters were also included in the study. Sequence analysis of
the androgen receptor gene (AR) revealed a novel A2933 in-
sertion that alters the Tyr codon to a termination codon
(Y857X), resulting in a truncated form of the receptor. Com-
puter simulation revealed major conformational changes in
the hydrophobic pocket that accommodates the hormone.
An insA2933 results in a truncated receptor incapable of bind-
ing the ligand and is responsible for the clinical symptoms of
CAIS in the patient. The levels of the AR transcript in periph-
eral blood leukocytes were higher in the patient than in her
heterozygous mother and her heterozygous sister, as well as in
the two healthy sisters. It is hypothesized that elevated levels
of the AR transcript in the patient might be caused by the
inability of the truncated receptor to react with IFI-16, which
functions in complex with AR to inhibit the expression of the
AR gene.
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Introduction
Androgens such as testosterone (T) and dihydrotestosterone
(DHT) affect the development and differentiation of the male
external genitalia during embryonic development and are re-
sponsible for virilization of the pubertal male (Wilson et al.
1981). These effects are mediated by an androgen receptor
(AR), which binds T and DHT with high affinity. Androgen
receptor regulates transcription by interaction with specific
androgen response elements (AREs) localized in the regulato-
ry regions of target genes (Lee and Chang 2003). The andro-
gen receptor gene (AR) is located on the X chromosome
(Xq11-13) and contains eight exons (Quigley et al. 1995).
Its protein product, AR, comprises an N-terminal part that is
responsible for the antigenic properties of the receptor and
contains the AF-1 sequence, which is responsible for activa-
tion of gene transcription. The DNA-binding domain (DBD),
located in the center, contains two zinc-finger motifs and is
responsible for binding to the AREs. The C-terminal part is
comprised of the ligand-binding domain (LBD) involved in
hormone binding, the AF-2 domain, the second sequence re-
sponsible for activation of target gene transcription, and the
region responsible for dimerization of the receptor. From the
crystalline structure of other members of the steroid receptor
superfamily, it can be inferred that the LBD, encoded by exons
4 through 8, consists of 12 α-helices and two β-sheets, and
includes a hydrophobic pocket that is located in the center of
the molecule (Griffin et al. 2001; Wurtz et al. 1996).
Genetic defects that alter the function of AR can cause a
wide range of abnormalities in male sexual development, and
the effects of these defects are collectively referred to as an-
drogen insensitivity syndrome (AIS).
These defects are transmitted in an X-linked recessive man-
ner and have a prevalence of about 1 in 65,000 individuals.
Three main phenotypic forms of AIS have been identified: a
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complete form (CAIS), a partial form (PAIS), and mild form
(MAIS). All patients with CAIS have a 46,XY karyotype and
possess a female phenotype with nearly normal female exter-
nal genitalia and breast development. Instead of female inter-
nal genitalia, they have testes located in the abdomen or in-
guinal canals. Their pubic hair is scarce and axillary hair is
absent. Testosterone levels are within the normal male range
and estradiol is within the normal female range, while serum
gonadotropin levels are normal or slightly elevated. The par-
tial form (PAIS) is characterized by a wide spectrum of phe-
notypes, ranging from an incomplete female phenotype
through various degrees of feminization of male external gen-
italia. In the mild form (MAIS), the phenotype is usually male
and the symptoms of feminization can be very weak (Quigley
et al. 1995; Sinnecker et al. 1997).
To date, more than 1,000 ARmutations have been described
(Gottlieb et al. 2012). Most of these mutations are point muta-
tions localized in the region encoding the LBD, particularly
within helices V and IX. However, only about 30 mutations
causing premature termination of translation due to generation
of a termination codon and resulting in a truncated form of the
receptor have been described (Gottlieb et al. 2012).
It has been demonstrated that androgens stimulate expres-
sion of a number of interferon-activated (IFI) genes belonging
to the p200 family. Their protein products are known to inhibit
cell cycle progression, modulate apoptosis, and act as negative
regulators of gene expression, including the AR gene (Xin
et al. 2003, 2004). In LNCaP prostate cancer cells transfected
with a plasmid expressing AR, it has been reported that the
IFI-16 protein product binds within the DBD of AR and
down-regulates AR and AR target gene expression (Alimirah
et al. 2006). Up-regulation of IFI-16 expression by AR could,
thus, provide an important element of the feedback loop that
negatively regulates transcription of the AR.
The present investigation was designed to identify molec-
ular defects in AR in a patient diagnosed with CAIS and to
estimate the level of AR expression in peripheral blood lym-
phocytes in this patient. An attempt was also made to explain
why the expression of AR was increased in this patient.
Case report
A 2-year-old girl (Fig. 1a, II-2) was admitted to the Department
of Pediatric and Adolescent Endocrinology, Polish-American
Children’s Hospital, Jagiellonian University, Cracow, Poland
to correct a bilateral inguinal hernia. The child had unambigu-
ous female external genitalia. The absence of female internal
genitalia, combined with male gonads found bilaterally in the
inguinal canals and a 46,XY karyotype, were consistent with
the diagnosis of CAIS. Histopathological evaluation of the ma-
terial removed revealed male gonad texture with lymphocyte
infiltration. There was no history of sexual development
disturbances in the family members. The patient’s mother
(I-1) and three healthy sisters (II-3, II-4, II-5), referred to the
hospital for genetic counseling, were also examined (Fig. 1).
The University Ethical Committee approved the study andwrit-
ten consent from the patient’s mother was obtained.
Materials and methods
Genomic DNA was extracted from peripheral blood leuko-
cytes of the patient, her mother, and her three sisters. Exons
2 through 8 of AR were amplified by polymerase chain reac-
tion (PCR) using Taq Polymerase (Fermentas, Lithuania) and
previously described primers (Turek-Plewa et al. 2006). The
PCR products were purified on DNAGel-Out columns (A&A
Biotechnology, Poland) and were screened using
multitemperature single-strand conformational polymorphism
(MSSCP) analysis to detect sequence-dependent differences
in the electrophoretic mobility. A CEQ 8000 DNA analyzer
(Beckman Coulter, USA) was used for direct DNA sequenc-
ing. In order to demonstrate conformational changes within
the region of AR where the mutation was located, a structural
analysis of the LBDwas conducted with the use of Swiss PDB
Viewer 3.7 software.
Total RNA was isolated from peripheral blood leukocytes
(Chomczynski and Sacchi 1987) using TRItidy reagent
(Applichem, Germany), and the RNA concentration was mea-
sured by spectrophotometry (Eppendorf, Germany). Poly A+
RNAwas transcribed with the use of Moloney murine leuke-
mia virus (MMLV) reverse transcriptase and random
hexamers (Novazym, Poznan, Poland), according to the man-
ufacturer’s instructions. AR and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) cDNAs were amplified (RT-qPCR
[reverse transcription quantitative PCR]) with the use of spe-
cific primers (Table 1).
Statistical analysis of the results was conducted with the aid
of GraphPad InStat v.3.05 software andMicrosoft Excel 2007.
The results are presented as the mean (±SD [standard devia-
tion]) of two repeats from three or more separate experiments
and were subjected to one-way analysis of variance
(ANOVA). All results were also tested with the post-hoc Stu-
dent–Newman–Keuls test. The significance of the differences
were tested at the level of p<0.05, p<0.01, or p<0.001.
Results and discussion
Diagnosis of the 2-year-old girl undergoing a procedure to
correct inguinal hernia was based on the following clinical
symptoms: unambiguous female external genitalia, the ab-
sence of internal female genitalia, male gonads found bilater-
ally in the inguinal canals, and 46,XY karyotype. Post-
operative histological examination of the gonads was
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consistent with the diagnosis of CAIS, as no signs of Wolffian
derivatives and male gonad texture were found.
Genetic investigation of the patient, her mother, and her
three healthy sisters (Fig. 1a) involved screening for mutations
in AR by MSSCP, followed by sequencing of the mutated
fragment and structural analysis of the protein product of the
gene in silico.
MSSCP analysis revealed an incorrect banding pattern of
amplified exon 7 in the patient, as well as in her mother and in
one of her 46,XX sisters, suggesting a possible mutation
(Fig. 1b). Direct sequencing of these fragments (Fig. 1c) re-
vealed an insA2993 mutation, which alters the Tyr857 codon
UAC to form a UAA termination codon. This mutation leads
to the truncation of the receptor by 62 amino acids at the C-
terminal end, resulting in an 856-amino-acid protein devoid of
a major part of the LBD. This mutation might result in an
inability of ligand to bind to AR and may, therefore, be re-
sponsible for the clinical symptoms of CAIS found in the





cDNA Forward primer Reverse primer Annealing (°C) Product (bp)
AR 5′-acgacaacaaccagcccgac-3′ 5′-gtgtaagttgcggaagccag-3′ 60 122
GAPDH 5′-ttcgtcatgggtgtgaacc-3′ 5′-gatgatgttctggagagccc-3′ 60 231














Fig. 1 Pedigree of the family (a),
multitemperature single-strand
conformational polymorphism
(MSSCP) analysis (b), and
sequence analysis of exon F (c) of
the AR gene. I-1, mother; II-2,
patient; II-3, II-4, and II-5, healthy
sisters; C, healthy individual
(control). The position of
insA2933 is indicated by an
arrow
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patient. The patient’s mother and one of the sisters (both car-
rying the 46,XX karyotype) are asymptomatic carriers of the
same mutation. To date, only about 30 nonsense mutations in
AR have been described (Gottlieb et al. 2012). In all cases, the
truncation of AR was responsible for the symptoms of the
disease. One of the previously described mutations located
in the same position, a C2933G transversion, led to a frame-
shift and a premature termination of translation (Hiort et al.
1998). However, to date, no functional assay of this truncated
receptor has been reported.
Structural analysis with the use of Swiss PDB Viewer 3.7
software (Fig. 2) demonstrated that Tyr857 is located within
the α-helix participating in the ligand binding. The truncated
protein lacks a major part of the LBD which is responsible for
the formation of the hydrophobic pocket and which, in turn,
accommodates the ligand. The mutation also leads to abolish-
ment of the β-pleated sheet that is normally located between
helices VIII and IX. Profound conformational changes might
severely impair or even abolish hormone binding by AR and
may lead to the clinical symptoms of CAIS in the patient.
In order to investigate the influence of the insA2933
mutation on the expression of AR, the level of the illegit-
imate transcripts in peripheral blood leukocytes was esti-
mated by real-time PCR in the patient, her mother, her
three sisters, and in a healthy individual of the same
sex. No difference in the AR transcript level between the
patient’s mother and three sisters (including an asymp-
tomatic carrier) was found, while in the patient, the AR
transcript level was significantly higher (p<0.001) than
that seen in her mother and three sisters (Fig. 3a).
It has been reported that androgens acting via AR stimulate
expression of IFI-16. The IFI-16 protein product then interacts
with the AR/ligand complex, which, in turn, inhibits expres-
sion of AR (Alimirah et al. 2006).
We hypothesize that the reason for higher AR expression in
the 2-year-old girl with CAIS (II-2) than in her heterozygous
mother (I-1), her heterozygous sister (II-3), and her two
healthy sisters (II-4 and II-5) is that the truncated receptor,




Fig. 2 Structural analysis of the
normal and mutated (Y857X)
ligand-binding domain (LBD) of
androgen receptor (AR) in the
patient (Swiss PDB Viewer 3.7






C II-2 I-1 II-3 II-4 II-5
p<0.001
Fig. 3 Relative levels of the AR transcript (A) in peripheral blood
leukocytes. (A) mRNA was isolated from peripheral blood leukocytes,
reverse transcribed, and the AR cDNA was amplified with the use of
specific primers (RT-qPCR [reverse transcription quantitative PCR]), as
detailed in the Materials and methods section. The results of individual
measurements were normalized to glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) and the expression level in the normal
individual was considered as 1.0. The results are represented as the
mean of three estimations from three separate experiments. C, healthy
individual (control); II-2, patient; I-1, mother; II-3, II-4, and II-5,
healthy sisters
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androgen binding and, hence, would be unable to stimulate
IFI-16 expression, because this requires a ligand–receptor
complex. Therefore, the protein product of the IFI-16 gene
will not be formed and the IFI-16–androgen complex could
not be formed and inhibit the expression of AR.
This hypothesis, however, should be substantiated by fur-
ther research using a group of CAIS patients with mutations
leading to truncation of the LBD of AR.
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